QualityDipStocks / Finance · Major Banks
Renasant RNST
Outside our quality screen, so we don’t track its dips. It’s 8% below its 52-week high.
Outside our quality screen, trading above our fair value estimate.
- Fair value est.
- $35.02−14%
- Market Value
- forming
- Off 52-wk high
- −8%
- Risk vs market
- Lowbeta 0.48
4 bullish · 4 bearish See why
Repriced or dip?
Near its high
The price is 8% below its 52-week high (Aug 4), but the business held up: earnings per share +42.0%, shares outstanding fewer shares, each owns more.
Some numbers held up (earnings per share +42.0%, shares outstanding fewer shares, each owns more), others slipped (revenue growth rate −18.1 pts). The price is 8% below its 52-week high.
The price is 8% below its 52-week high, and the business changed too: revenue growth rate −18.1 pts.
Within 10% of its 52-week high, so there is no dip to judge yet.
Data-based read, not advice.
Priced in
How much growth the market assumed at the 52-week high, the low and today (a reverse DCF).
52-wk high: P/E 18.3×; 52-wk low: P/E 21.6×; now: P/E 11.8×.
| High | Low | Now | |
|---|---|---|---|
| Price | $44.30Aug 4 | $33.40Nov 17 | $40.55 |
| P/E | 18.3× | 21.6× | 11.8× |
What this means: a lower P/E than at the high means you pay less for each dollar of profit than buyers did then.
How it’s computed
Banks, insurers and lenders: cash flow includes deposits and loans, so a cash-flow model doesn't fit; we show P/E at each point instead. P/E = that day's close × diluted shares / 12-month net income, using only the filings that were public on that day.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
How the range is computed
Financials model (residual income). Same residual-income model as the base: cost of equity 9.5% ±1 point and return on equity 7.4% ±2 points. Bear = 10.5% and 5.4%; bull = 8.5% and 9.4%. A model estimate from public filings, not a forecast of where the price will go.
Price sits inside the range.
What the price implies To be worth today’s price, RNST would need a return on equity of about 9% a year; our estimate uses 7%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much RNST moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Moves much less than the market, but its own price swings are 1.8× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- 0.48
- Volatility
- 23% vs 13% SPY
- Correlation SPY
- 0.27
- Correlation QQQ
- 0.10
How it ranks
Where RNST stands vs every one of the 1,996 stocks we cover that has the number. Longer bar = better.
Top quarter on 2 of 3 measures
- Discount to fair value estimate14% · price above our base caseLowest 42%of 1,314
- Dividends + buybacks yield6.4% · cash paid out or used to retire shares, vs market capTop 17%of 1,836
- Revenue growth, last 12 months+33% · vs the 12 months beforeTop 14%of 1,814
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
DCF $35.02
Financials model (residual income): book value $43.49 a share on Jun 30, 2026, plus the earnings above a 9.5% cost of equity. ROE 7.4%, the average of 8.0% for the trailing 12 months to Jun 30, 2026 and 6.8% over fiscal 2021–2025, on average common equity; payout 69% of earnings (dividends 28% + net buybacks 41%), so book grows by the retained rest; the return above 9.5% fades halfway toward 9.5% over 10 years, then grows at 3% (terminal value). From the 10-Q filed Aug 5, 2026.
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 4 of 5
GrowthSales grew 33% to $1.1B over the last 12 months vs the 12 months before (SEC filings).
GrowthSales compounded 16% a year from FY2022 to FY2025.
Cash returnsShare count down 3.1% in a year: $150M of buybacks over 12 months.
Cash returnsDividend yield of 2.3% ($87M paid over 12 months, 28% of earnings).
Top bearish points 4 of 5
ValuationOur residual-income fair value estimate is $35.02, 14% below the price.
GrowthDiluted EPS fell 37% to $2.07 in FY2025.
ProfitabilityReturn on equity of 8.2%, below the 12% median for the 291 Finance companies we cover.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%.
All fundamentals
P/E 11.8 · ROE 8% · Sales +33%
Valuation
- P/E
- 11.8×Finance median 13.6×
- Price / FCF
- n/acash flow isn't a clean measure for a bank
- FCF yield
- n/acash flow isn't a clean measure for a bank
- EV / EBITDA
- n/anot meaningful for a bank
- Price / sales
- 3.38×
- Price / book
- 0.96×
- Market cap
- $3.7Bprice × diluted shares
- Enterprise value
- $3.9B
Growth
- Revenue, 12 months
- $1.1Bnet interest income + noninterest income
- Sales growth, 12 months
- +32.8%vs the 12 months before
- Sales growth, 3 yrs
- +16.1%/yrfrom FY2022
- Diluted EPS, 12 months
- $3.42
- EPS growth, last FY
- −36.7%
- Net income, 12 months
- $314M
- Net income growth
- +97%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for a bank
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- 28.7%
- FCF margin
- 36.8%
- Return on equity
- 8%
- Return on invested capital
- n/anot meaningful for a bank
Balance sheet
- Cash & short-term inv.
- $881M
- Total debt
- $1.1B
- Net cash
- n/anot meaningful for a bank
- Debt / equity
- n/adeposits/float make debt/equity not comparable for a bank
- Interest coverage
- n/anot meaningful for a bank
Cash flow & returns
- Free cash flow, 12 months
- $403M
- FCF growth, 12 months
- +358%
- Dividend yield
- 2.35%$87M paid
- Payout ratio
- 28%
- Buybacks, 12 months
- $150M4.0% of market cap
- Share count, 1 year
- −3.1%diluted shares vs a year ago
- Stock-based comp
- $19M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From Renasant’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.4B · Sales 0%
- Free cash flow, 12 months$0.4B
- Free-cash-flow yield10.8%
- Return on equity9%
- Sales growth (latest quarter vs year-ago quarter)0%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $40.55
- 52-wk lowlowest close, 1 year$33.40−17.6%
- Fair value est.base case$35.02−13.6%
- PriceMon Nov 2 close$40.55you are here
- 52-wk highhighest close, 1 year$44.30+9.2%
Momentum & 52-week range
RSI 52 · 5 days −2.9%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
RNST is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Renasant in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Major Banks
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.